Open-house discount agreements for etanercept medicines, ATC L04AB01

Summary

This is an open-house model for non-exclusive discount agreements covering the medicine etanercept, ATC L04AB01. AOK Bayern intends to conclude identical, non-negotiable agreements with every interested pharmaceutical company that meets the stated requirements; there is no competitive selection between suppliers. The earliest contract start date is 1 November 2026, and the agreements end on 31 October 2028. Complete and correct documents may be submitted during the contract period, but no later than 3 September 2028. The supplier must provide the signed agreement, the completed schedule identifying the medicines covered by the agreement, and a signed reliability declaration. Documents may be submitted as two signed paper originals or electronically with a qualified electronic signature. The detailed tender documents must be checked before participation.